Survival Impacts of Impaired Lung Functions and Comorbidities on Elderly Esophageal Cancer Patients

被引:3
|
作者
Sugawara, Kotaro [1 ]
Oka, Daiji [1 ]
Hara, Hiroki [2 ]
Yoshii, Takako [2 ]
Fukuda, Takashi [1 ]
机构
[1] Saitama Canc Ctr, Dept Gastroenterol Surg, 780 Komuro Inamachi, Saitama 3620806, Japan
[2] Saitama Canc Ctr, Dept Gastroenterol, Saitama, Japan
关键词
LONG-TERM OUTCOMES; PULMONARY-FUNCTION; OLDER PATIENTS; CO-MORBIDITY; AGE; HEALTH;
D O I
10.1007/s00268-023-07195-y
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Preoperative physiological assessments are crucial for optimizing clinical outcomes, especially those of elderly esophageal cancer (EC) patients who are generally frail and at the high risk of mortality.Methods Patients who underwent surgery for EC between 2004 and 2018 were retrospectively reviewed. Patients were categorized into elderly (>70 years) or non-elderly (<= 70 years) groups. Various physiological parameters including the Charlson Comorbidity Index (CCI), immunonutritional parameters and pulmonary functions were studied. Pulmonary functions included %vital capacity (VC) and forced expiratory volume in one second (FEV1.0) and FEV1.0%. The thresholds were set as the lowest quartile (100% for %VC and 2L for FEV1.0) in this cohort. Multivariate Cox hazards models were applied to determine independent predictors of non-EC-related deaths.Results In total, 824 patients were included (elderly; n = 306, non-elderly; n = 518). Elderly patients had a significantly lower 5-year OS rate than non-elderly patients (53.3% vs. 57.2%, P = 0.03), mainly due to increased risk of death from non-EC related causes. In the elderly group, multivariate Cox hazards analysis identified 3 independent predictors of non-EC-related deaths; high CCI (HR 1.98, P=0.006), low %VC (HR 2.01, P = 0.004) and low FEV1.0 (HR 1.6, P=0.048). Elderly patients without risk factors had a significantly better 5-year OS rate (63.5%) than those with 1 (50.0%) or 2-3 (36.3%) risk factors (P <0.01). Deaths due to pulmonary disease rose significantly as the number of risk factors increased (P=0.03).Conclusions The severity of comorbidities and pulmonary function impairments are useful for predicting long-term outcomes, especially non-EC-related deaths, in elderly EC patients.
引用
收藏
页码:3229 / 3239
页数:11
相关论文
共 50 条
  • [1] Survival Impacts of Impaired Lung Functions and Comorbidities on Elderly Esophageal Cancer Patients
    Kotaro Sugawara
    Daiji Oka
    Hiroki Hara
    Takako Yoshii
    Takashi Fukuda
    World Journal of Surgery, 2023, 47 : 3229 - 3239
  • [2] IMPACT OF COMORBIDITIES ON SURVIVAL IN ELDERLY PATIENTS WITH NON SMALL CELL LUNG CANCER
    Kaya, Metin
    Dizdar, Omer
    Rahatli, Samed
    Kucukoztas, Nadire
    Yalcin, Selim
    Altundag, Ozden
    Ozyilkan, Ozgur
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S882 - S882
  • [3] Impact of Comorbidities on Survival in Gastric, Colorectal, and Lung Cancer Patients
    Morishima, Toshitaka
    Matsumoto, Yoshifumi
    Koeda, Nobuyuki
    Shimada, Hiroko
    Maruhama, Tsutomu
    Matsuki, Daisaku
    Nakata, Kayo
    Ito, Yuri
    Tabuchi, Takahiro
    Miyashiro, Isao
    JOURNAL OF EPIDEMIOLOGY, 2019, 29 (03) : 110 - 115
  • [4] Survival in elderly patients undergoing lung resection for lung cancer
    Vukoja, Marija
    Kopitovic, Ivan
    Djuric, Dejan
    Milicic, Dragana
    Bokan, Aleksandar
    Cikara, Radmila
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [5] Navelbine increases elderly lung cancer patients' survival
    不详
    ONCOLOGY-NEW YORK, 1999, 13 (03): : 435 - 435
  • [6] Prevalence of comorbidities in elderly cancer patients
    Wenkstetten-Holub, Alfa
    Fangmeyer-Binder, Maria
    Fasching, Peter
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2021, 14 (01) : 15 - 19
  • [7] Prevalence of comorbidities in elderly cancer patients
    Alfa Wenkstetten-Holub
    Maria Fangmeyer-Binder
    Peter Fasching
    memo - Magazine of European Medical Oncology, 2021, 14 : 15 - 19
  • [8] IMPACTS OF CEREBROVASCULAR AND NEURODEGENERATIVE DISEASES ON SURVIVAL OF LUNG CANCER PATIENTS
    Kravchenko, J.
    Berry, M. F.
    Arbeev, K. G.
    Lyerly, H.
    Yashin, A. I.
    Akushevich, I.
    GERONTOLOGIST, 2015, 55 : 496 - 496
  • [9] CARDIOVASCULAR COMORBIDITIES IN LUNG CANCER PATIENTS: TREATMENT-SPECIFIC EFFECTS ON SURVIVAL
    Kravchenko, J.
    Berry, M. F.
    Arbeev, K. G.
    Akushevich, I.
    GERONTOLOGIST, 2014, 54 : 122 - 122
  • [10] Cardiovascular comorbidities and survival of lung cancer patients: Medicare data based analysis
    Kravchenko, Julia
    Berry, Mark
    Arbeev, Konstantin
    Lyerly, H. Kim
    Yashin, Anatoly
    Akushevich, Igor
    LUNG CANCER, 2015, 88 (01) : 85 - 93